[1]
Aiello, A., Mancuso, M.E., Colombo, A., Teruzzi, C. and Berto, P. 2020. Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B. Global and Regional Health Technology Assessment. 7, 1 (Jul. 2020), 40–49. DOI:https://doi.org/10.33393/grhta.2020.2113.